✦ LIBER ✦

Localization of 2′,5′-oligoadenylate synthetase and the enhancement of its activity with recombinant interferon-α A/D in the mouse brain

✍ Scribed by Mari Asada-Kubota; Tetsuo Ueda; Toshihiro Nakashima; Mikiko Kobayashi; Mamoru Shimada; Kazumasa Takeda; Kazushige Hamada; Shohei Maekawa; Y. Sokawa

Book ID: 106119472
Publisher: Springer
Year: 1997
Tongue: English
Weight: 868 KB
Volume: 195
Category: Article
ISSN: 0340-2061
DOI: 10.1007/s004290050044

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epidermal growth factor-urogastrone acti

Epidermal growth factor-urogastrone action: Induction of 2′, 5′-oligoadenylate synthetase activity and enhancement of the mitogenic effect by anti-interferon antibody

✍ Stanley L. Lin; P.O.P. Ts'o; Morley D. Hollenberg 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 645 KB

Clinical trials of a recombinant gamma i

Clinical trials of a recombinant gamma interferon 1. Effects of the gamma interferon administered intramuscularly or by inhalation on circulating interferon and 2,5-oligoadenylate synthetase and protein kinase activities

✍ T. M. Sokolova; O. A. Lopatina; N. N. Nosik; S. K. Cheshik 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 290 KB

Functional differences in the promoters

Functional differences in the promoters of the interferon-inducible (2′-5′)A oligoadenylate synthetase and 6–16 genes in interferon-resistant Daudi cells

✍ Matthew J. GUILLE; Carl D. LAXTON; Michael N. RUTHERFORD; Bryan R. G. WILLIAMS; 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 945 KB

5-fluorouracil and low-dose recombinant

5-fluorouracil and low-dose recombinant interferon-α-2a in patients with hormone-refractory adenocarcinoma of the prostate

✍ Shinohara, Nobuo; Demura, Takayoshi; Matsumura, Kin-ya; Toyoda, Ken-ichi; Kashiw 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB 👁 1 views

## Background: The effectiveness of a chemotherapy regimen including 5-fluorouracil (5-fu) and recombinant interferon-alpha-2a (rifn-alpha-2a) was evaluated in hormone-refractory prostate cancer patients. ## Methods: Patients received a continuous intravenous infusion of 5-fu at 600 mg/m2/day for

2–5A synthetase activity does not increa

2–5A synthetase activity does not increase in interferon-resistant friend leukemia cell variants treated with α/β interferon despite the presence of high-affinity interferon receptor sites

✍ E. Affabris; G. Romeo; F. Belardelli; C. Jemma; N. Mechti; I. Gresser; G.B. Ross 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 420 KB

Recombinant interferon α-2A combined wit

Recombinant interferon α-2A combined with prednisone in metastatic renal-cell carcinoma: Treatment results, serum interferon levels and the development of antibodies

✍ Sophie D. Fosså; Gustav Lehne; Ragnhild Gunderson; Unni Hielmaas; Eduard E. Hold 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 French ⚖ 375 KB 👁 1 views

Five partial responses were seen in 23 patients with metastatic renal-cell carcinoma (MRCC) receiving interferon-a 2a (IFN) + prednisone (P). Four of 24 subsequent patients responded to IFN + P (combined response rate 19%). The median response duration was 8 months (3 to 30 months). The one-year sur